Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2018, Article ID 4565216, 6 pages
https://doi.org/10.1155/2018/4565216
Clinical Study

Refractive and Biometric Outcomes in Patients with Retinopathy of Prematurity Treated with Intravitreal Injection of Ranibizumab as Compared with Bevacizumab: A Clinical Study of Correction at Three Years of Age

1Department of Ophthalmology, Changhua Christian Hospital, Changhua, Taiwan
2School of Medicine, Chung Shan Medical University, Taichung, Taiwan
3Department of Optometry, DaYeh University, Changhua, Taiwan
4School of Medicine, National Taiwan University, Taipei, Taiwan

Correspondence should be addressed to San-Ni Chen; wt.gro.hcc@265801

Received 7 November 2017; Accepted 14 January 2018; Published 11 March 2018

Academic Editor: Toshihide Kurihara

Copyright © 2018 Yen-Chih Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Yen-Chih Chen, San-Ni Chen, Benjamin Chi-Lan Yang, Kun-Hsien Lee, Chih-Chun Chuang, and Chieh-Yin Cheng, “Refractive and Biometric Outcomes in Patients with Retinopathy of Prematurity Treated with Intravitreal Injection of Ranibizumab as Compared with Bevacizumab: A Clinical Study of Correction at Three Years of Age,” Journal of Ophthalmology, vol. 2018, Article ID 4565216, 6 pages, 2018. https://doi.org/10.1155/2018/4565216.